Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Blacksmith Medicines to Present at the Gordon Research Conference on New Antibacterial Discovery and Development
PR Newswire, 2024
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Blacksmith Medicines Announces $3.3M in Funding from NIAID to Support Clinical Trial Manufacturing of Novel Antibiotic
PR Newswire, 2024
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
MicuRx: Successful Completion of Phase I Clinical Trial for Self-Developed MRX-8 Antibacterial Drug in China
PR Newswire, 2024
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Qpex Biopharma, a Shionogi Group Company, Receives an Additional $10M Award by BARDA as Part of Qpex’s Partnership to Advance its Portfolio of Antibiotics Addressing Drug-Resistant Infections
Business Wire, 2024
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Shoreline Biome Launches the Shoreline Breaker Instrument and HMW DNA Sample Prep Kits to Advance Microbiome Research: Ensure no microbe is left behind - Fast-track microbiome metagenomic analysis with Shoreline BreakerTM Instrument and HMW DNA Prep Kits
PR Newswire, 2021
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Seres Therapeutics Presents SER-109 ECOSPOR IV Study Data at IDWeek and American College of Gastroenterology (ACG) 2022 Annual Meetings
Business Wire, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
ATMOFIZER TECHNOLOGIES INC. ANNOUNCES HVAC MARKET DEVELOPMENT AND THIRD QUARTER 2022 FINANCIAL RESULTS
PR Newswire, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Venatorx Announces Presentation of Analysis of Cefepime-Taniborbactam in vitro Activity against Clinically Significant Gram-Negative Bacteria Isolated from Patients with Cancer at IDWeek 2023
Business Wire, 2023
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Venatorx Pharmaceuticals to Present at IDWeek 2023
Business Wire, 2023
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Venatorx Pharmaceuticals to Present at IDWeek 2022
Business Wire, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Vedanta Biosciences Presents Progress from Two Defined Bacterial Consortia, VE303 for the Prevention of C. difficile and VE707 for the Prevention of Gram-Negative Infections, at IDWeek 2023
Business Wire, 2023
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Drug Candidate for 300 Drug-Resistant Bacteria
FARS News Agency, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Achaogen furnishes data for Pew antibiotic platform targeting Gram-negative bacteria
M2 Presswire, 2018
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO® (sulbactam for injection; durlobactam for injection), Co-packaged for Intravenous Use
Business Wire, 2023
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
Business Wire, 2024
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review
Pakistan Press International, 2024
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Cellex, Inc., Part of the Avioq Family of Companies, Receives NIH Grant to Develop Rapid Test for Detection of Carbapenemase Producing Organisms (CPOs)
Business Wire, 2016
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Forge Enters Into Collaboration With Roche To Develop Novel Antibiotic To Treat Lung Infections: Forge is eligible to receive $190.5M in total payments
PR Newswire, 2020
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
FDA Clears Expanded Claims for 'Superbug' Test: Xpert® Carba-R now FDA-cleared to aid clinicians in determining appropriate therapeutic strategy for pure colony specimens
PR Newswire, 2018
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Cepheid | FDA Clears Expanded Claims for 'Superbug' Test
M2 Presswire, 2018
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Forge Therapeutics Achieves CARB-X Milestone for FG-LpxC LUNG Antibiotic Program
PR Newswire, 2021
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
ATMOFIZER TECHNOLOGIES INC. Announces LATEST Independent test results
PR Newswire, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Qpex Biopharma Announces Presentations on Phase 1 and Nonclinical Data on Three Clinical Stage Oral and IV Products Targeting Antibiotic-Resistant Bacterial Infections at 2022 ID Week Meeting
Business Wire, 2022
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Forge Therapeutics Announces Novel Antibiotic Presentation at the American Society of Microbiology Conference on Antibacterial Development
PR Newswire, 2016
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Blood Culture Tests Market worth $7.6 billion | MarketsandMarkets
PR Newswire, 2023
2023
Volltextzugriff (PDF)
1 – 25 von 181
Suche als RSS-Feed
Aktive Filter
KollektionOxford Journals
PublikationsformNewsletter-Artikel
Suchergebnisse filtern
Filter anzeigen